Investing Ideas
/
Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

5 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
HLUN B H. Lundbeck	DKK 40.26	-0.8%	16.8%	DKK 38.4b	DKK 50.15	PE14.9x	E7.4%	1.7%
GMAB Genmab	DKK 1,509.50	-6.1%	-23.9%	DKK 95.9b	DKK 2,314.56	PE20.4x	E21.8%	n/a
BAVA Bavarian Nordic	DKK 196.35	-2.6%	23.3%	DKK 15.4b	DKK 305.00	PE13.8x	E3.4%	n/a
HLUN A H. Lundbeck	DKK 32.45	-1.5%	9.7%	DKK 38.4b	DKK 40.42	PE14.9x	E7.4%	1.7%
NOVO B Novo Nordisk	DKK 575.60	-9.0%	-21.4%	DKK 2.6t	DKK 830.68	PE27x	E13.5%	1.7%

Page 1 of 1